Danaher Corporation
DHR
Delayed Nyse - 05/26 06:18:23 pm
84.2USD
-0.37%
Healthcare
Healthcare Services
 Healthcare Equipment & Supplies
  Advanced Medical Equipment & Technology
   Advanced Medical Equipment & Technology - NEC
Designs, manufactures & markets industrial instruments and machinery

Danaher Corp. operates as a medical company, which designs, manufactures, and markets healthcare, environmental, and industrial equipment.

It operates through the following segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.

The Life Sciences segment offers a range of research and clinical tools that scientists use to study cells and cell components in order to understand the causes of diseases; identify new therapies; and test new drugs and vaccines.

The Diagnostics segment comprises of analytical instruments, reagents, consumables, software, and services that hospitals, physician's offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions.

The Dental segment develops products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums, and supporting bones; as well as provide dental consumables, equipment, and services.

The Environmental & Applied Solution segment engages in the development and manufacture of equipment, consumables, and software for various printing, marking, coding, design, and color management applications on consumer and industrial products.

The company was founded by Steven M. Rales and Mitchell P. Rales in 1969 and is headquartered in Washington, DC.

Number of employees : 62 000 persons.
Sales per Businesses
20152016
USD
(in Million)
%USD
(in Million)
%
Life Sciences & Diagnostics8,21339.9%--
Environmental3,63517.7%--
Industrial Technologies3,32316.2%--
Dental2,73713.3%2,78516.5%
Test & Measurement2,65512.9%--
Other----
Life Sciences--5,36631.8%
Diagnostics--5,03829.8%
Environmental & Applied Solutions--3,69321.9%
Sales per Regions
20152016
USD
(in Million)
%USD
(in Million)
%
United States9,07344.1%6,37737.8%
All Other8,37740.7%6,75740%
China1,9909.7%1,79910.7%
Germany1,1245.5%1,0856.4%
Japan--864.705.1%
United Kingdom----
Shareholders
- T. Rowe Price Associates, Inc.8.06%
- Stephen M. Rales6.22%
- The Vanguard Group, Inc.5.90%
- Mitchell P. Rales5.57%
- BlackRock Fund Advisors3.96%
- SSgA Funds Management, Inc.3.64%
Managers
- President, Chief Executive Officer & Director :
    Thomas Joyce
- Chairman :
    Steven Rales
- Chief Financial Officer & Executive Vice President :
    Daniel Comas
- Independent Director :
    Alan Spoon
- Lead Independent Director :
    Donald Ehrlich
- Independent Director :
    Walter Lohr
- Director :
    Mitchell Rales
- Independent Director :
    Linda Filler
- Independent Director :
    John Schwieters
- Independent Director :
    Elias Zerhouni
Company contact information
Suite 800W 2200 avenue Pennsylvania
US-DC 20037 Washington, D.C.
États-Unis (les)

Phone : +1 202 828 0850
Fax : +1 202 828 0860
Internet : http://www.danaher.com
Markets and indexes
- NYSE
- Main Market
- SP100 / SP500, Stoxx Global 200
Stock Exchange Codes
- ISIN Code :  US2358511028
Overall rating
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision